From GlobeNewswire: 2024-11-18 09:00:00

The Biochips Market was valued at USD 10.35 billion in 2023 and is projected to reach USD 35.00 billion by 2032, with a CAGR of 14.52% from 2024 to 2032. The market is driven by the demand for personalized medicine, genetic testing, and advanced diagnostics, with key players like Thermo Fisher Scientific and Illumina leading the way.

DNA chips hold the largest market share, essential for genetic testing and personalized medicine. Lab-on-a-chip (LOC) technology is the fastest-growing segment, offering efficient diagnostic solutions. Microarrays dominate the technology market, while microfluidics is experiencing rapid growth due to demand for portable diagnostic devices.

North America leads the biochips market, driven by research, advanced healthcare infrastructure, and companies like Thermo Fisher Scientific. The Asia Pacific region is expected to show the highest growth rate, with countries like China and India emerging as key players in the adoption of advanced diagnostic technologies.

Recent developments include Visionary Holdings Inc. partnering with B. Braun Biochip Technology Group to form Visionary Biotechnology Group Co., Ltd., and Randox Laboratories Ltd. launching a pioneering biochip for detecting the genetic risk of type 1 diabetes. The biochips market is expected to grow significantly due to technological advancements and increased demand for personalized medicine. With DNA chips, microarrays, and lab-on-a-chip devices, accuracy and efficiency in diagnostics are improving. The market is poised for rapid growth in the next decade, driven by rising chronic disease prevalence and a shift towards precision medicine.

The biochips market report covers key points like market definition, scope, and research assumptions. It also includes an executive summary, regional synopsis, and competitive analysis. The research methodology involves top-down and bottom-up approaches, data validation, and primary interviews. Statistical insights and trends reporting provide data on incidence, prescription trends, device volume, and healthcare spending.

The competitive landscape section lists major companies and includes market share analysis, product benchmarking, and strategic initiatives. Market segmentation by type includes DNA chips, lab-on-a-chip, and protein chips. Segmentation by technology covers microarrays and microfluidics. End-user segmentation includes biotechnology companies, hospitals, and diagnostics centers. Regional analysis and company profiles are also included in the report.

For more information and customization options, visit the complete biochips market report for 2024-2032 at https://www.snsinsider.com/reports/biochips-market-4577. S&S Insider is a leading market research and consulting agency, providing clients with current, accurate market data and insights to make informed decisions. Contact [email protected] for more information.



Read more at GlobeNewswire: Biochips Market to Grow Steadily with 14.52% CAGR,